» Articles » PMID: 32355795

GeneXpert MTB/RIF Assay with Transbronchial Lung Cryobiopsy for Mycobacterium Tuberculosis Diagnosis

Overview
Journal Ann Transl Med
Date 2020 May 2
PMID 32355795
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early tuberculosis (TB) diagnostic is one of the critical steps to TB control. GeneXpert MTB/RIF has been widely proven for a prompt TB diagnosis. The use of GeneXpert MTB/RIF assay with transbronchial lung cryobiopsy samples may increase diagnostic accuracy. We aim to assess the diagnostic of TB with GeneXpert MTB/RIF assay with transbronchial lung cryobiopsy.

Methods: Patients with suspected diagnosis of TB and negative smear microscopies, with TB culture and GeneXpert MTB/RIF assay with transbronchial lung cryobiopsy were included in this cross-sectional study. Participants were enrolled from 2016 to 2018 at National Institute of Respiratory Diseases, Mexico.

Results: We included 54 patients (77.8% males) aged 30 to 65 years. The sensitivity of the GeneXpert MTB/RIF assay with transbronchial lung cryobiopsy was 81.3% (95% CI, 62.1-100%), with a specificity of 100% (95% CI, 100-100%) and a negative predictive value of 92.7% (95% CI, 84.7-100%). Twenty-two patients of the total population have HIV, the sensitivity of the test in these patients was 87.5% (95% CI, 64.6-100%). Also, 28 patients with a peripheral localized lesion which had a solid pattern were identified (51.9%). The sensitivity in patients with peripheral localized lesions was 88.9% (68.4-100%).

Conclusions: The GeneXpert MTB/RIF assay with transbronchial lung cryobiopsy test is as efficient as broncho alveolar lavage for TB diagnosis. Transbronchial lung cryobiopsy increases a major diagnostic opportunity when the nature of illness is malignant. Transbronchial lung cryobiopsy is efficient in HIV patients, especially in patients with peripheral localized lesion.

Citing Articles

Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China.

Wei L, Chen J, Deng Z, Zhang Z, Zhang Z, Duan Q Front Public Health. 2025; 13:1442987.

PMID: 39935875 PMC: 11810889. DOI: 10.3389/fpubh.2025.1442987.


Establishment of an indirect ELISA for Mycobacterium tuberculosis MTB39A protein antibody.

Wang P, Cai Y, Zhang G, Jiang L, Li Y Appl Microbiol Biotechnol. 2023; 107(20):6339-6349.

PMID: 37597020 PMC: 10560182. DOI: 10.1007/s00253-023-12715-w.


The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review.

Li Z J Anal Methods Chem. 2022; 2022:2915018.

PMID: 36284547 PMC: 9588380. DOI: 10.1155/2022/2915018.


Performance Comparison of GeneXpert MTB/RIF, Gene Chip Technology, and Modified Roche Culture Method in Detecting and Drug Susceptibility in Sputum.

Xie C, Hu X, Liu Y, Shu C Contrast Media Mol Imaging. 2022; 2022:2995464.

PMID: 35935306 PMC: 9314178. DOI: 10.1155/2022/2995464.


Diagnostic Efficacy of Xpert MTB/RIF Assay in Bronchoalveolar Lavage Fluid for Tracheobronchial Tuberculosis: A Retrospective Analysis.

Sun Y, Zhang Q, Zhang Q, Liu C, Zhang H, Fu Y Front Med (Lausanne). 2021; 8:682107.

PMID: 34485328 PMC: 8416264. DOI: 10.3389/fmed.2021.682107.


References
1.
Lu Y, Zhu Y, Shen N, Tian L, Sun Z . Evaluating the diagnostic accuracy of the Xpert MTB/RIF assay on bronchoalveolar lavage fluid: A retrospective study. Int J Infect Dis. 2018; 71:14-19. DOI: 10.1016/j.ijid.2018.01.030. View

2.
Walters E, Goussard P, Bosch C, Hesseling A, Gie R . GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot study. Pediatr Pulmonol. 2013; 49(11):1133-7. DOI: 10.1002/ppul.22970. View

3.
Ali M, Trick W, Mba B, Mohananey D, Sethi J, Musani A . Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: A systematic review and meta-analysis. Respirology. 2017; 22(3):443-453. DOI: 10.1111/resp.12980. View

4.
Zawedde-Muyanja S, Manabe Y, Sewankambo N, Nakiyingi L, Nakanjako D . Xpert MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis. Int J Tuberc Lung Dis. 2019; 22(12):1475-1480. PMC: 6306042. DOI: 10.5588/ijtld.17.0460. View

5.
Rakotoarivelo R, Ambrosioni J, Rasolofo V, Raberahona M, Rakotosamimanana N, Andrianasolo R . Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar. Int J Infect Dis. 2018; 69:20-25. DOI: 10.1016/j.ijid.2018.01.017. View